AGP Executive Report
Last update: 2 hours agoBiotech Breakthrough: Qurient’s selective CDK7 inhibitor Q901 (mocaciclib) boosts topoisomerase I antibody-drug conjugates, with a new Science Advances paper pointing to a MYC/E2F-driven, HRR-suppressed mechanism. Cancer Diagnostics: A laser-based method can detect the colorectal cancer biomarker CEACAM-5 in blood in minutes, aiming to speed up and simplify liquid biopsy workflows. Cell Biology: Researchers map a druggable pathway controlling TFEB, a master regulator of cellular waste recycling, potentially unlocking new treatments for lysosomal disorders and cancer. Space Tech: Star Catcher plans an October Protostar test for wireless optical power transfer between spacecraft—an early step toward an orbital energy network. AI & Defense: Canada’s DND/CAF outlines an AI strategy focused on faster decision cycles, ethics/safety, talent, and partnerships to become AI-enabled by 2030. Healthcare Policy: The FDA is recruiting scientific and consumer members for advisory committees, with deadlines in November. Public Health & Safety: Rutgers reports benzodiazepine prescriptions fell 26.7% from 2013–2024, suggesting more cautious prescribing. Energy & Industry: Kenya’s Ruto backs Dangote’s refinery model as Lamu’s $16B project breaks ground, pushing local processing for regional industrial growth.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
![<![CDATA[A Leadership Call to Action for Biotech]]>](https://2c717466dc25cd7041c9-8eeda6a8ca964cf210ed223dbc947813.ssl.cf2.rackcdn.com/26736901-927244921-af1515bbced026909f04aa68aa61c16a66be284b-1280x701-100x55.jpeg)
